21Shares Ethereum ETF 8-K

What Happened 21Shares US LLC (the Sponsor) announced on June 30, 2026 that it has provided notice to CF Benchmarks Ltd. to terminate the Pricing Benchmark Licensing Agreement, effective August 31, 2026. The agreement covered use of the CME CF Ether‑Dollar Reference Rate — New York Variant to value the Trust’s shares and calculate its net asset value (NAV). The Sponsor intends to enter a licensing agreement with FTSE International Limited on or about August 24, 2026 to obtain FTSE index data for the Trust.

Key Details

• Notice of termination sent June 30, 2026; termination effective August 31, 2026.
• Current benchmark: CME CF Ether‑Dollar Reference Rate — New York Variant (licensed from CF Benchmarks).
• New provider: FTSE International Limited — license expected on/around August 24, 2026; one‑year initial term with automatic one‑year renewals.
• Both CF Benchmarks and FTSE are unaffiliated with the Sponsor; the Pricing Benchmark is used daily to value shares and calculate NAV.

Why It Matters The Trust is changing the data provider used to value shares and calculate NAV, which is a core operational input for pricing the ETF. This filing notifies investors of the provider switch and the effective timing; investors should watch for any future disclosures that describe differences in benchmark methodology or operational effects. There is no disclosure in the 8‑K of changes to the Trust’s investment objective or a stated impact on fees.